Sign up
Quantellect · Congress · Congressional Trade

Kevin Hern sold Medtronic PLC (NYSE: MDT)

Kevin Hern sold Medtronic PLC (MDT), disclosed September 1, 2026

Kevin Hern sold MDT · disclosed September 1, 2026

Kevin Hern, a OK House member representing District 1, sold $15,001 - $50,000 of Medtronic PLC (MDT) on August 24, 2026. Filings associated with Kevin Hern disclosed 1 other MDT transaction (1 sale) in the 12 months before this trade. Shares of MDT have risen 7.1% since the first observed purchase on November 7, 2019. The filing was publicly disclosed on September 1, 2026; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Kevin Hern's complete filing history, visit Kevin Hern's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on MDT break down as 0 strong buy, 15 buy, 6 hold, 0 sell, 0 strong sell.
  • MDT carries a Risk Score of 99 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
  • Kevin Hern sold MDT in the amount range of $15,001 - $50,000 on August 24, 2026, filed under the STOCK Act.
  • The filing lists Joint as the transaction owner and was disclosed 8 days after the trade.
  • The asset description in the filing reads 'Medtronic plc. Ordinary Shares (MDT) [ST].'
  • Filings associated with Kevin Hern disclosed 1 other MDT transaction (1 sale) in the 12 months before this trade.
  • Shares of MDT have risen 7.1% since the first observed purchase on November 7, 2019.
  • MDT carried a Q Score of 72.3 in its equity peer group as of September 4, 2026.
  • MDT carried a Squeeze Score of 13 as of September 8, 2026.

Did Kevin Hern buy or sell MDT?

The Periodic Transaction Report covers a single sale involving MDT on August 24, 2026. The filed amount range is $15,001 - $50,000. The asset description reads 'Medtronic plc. Ordinary Shares (MDT) [ST]', as submitted by the filer. The report was submitted on September 1, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Kevin Hern (House)SellMDT$15,001 - $50,000August 24, 2026September 1, 2026

What other MDT trades has Kevin Hern disclosed in the past 12 months?

Filings associated with Kevin Hern disclosed 1 other MDT transaction (1 sale) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
March 20, 2026SellJoint$15,001 - $50,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a sale involving MDT by Kevin Hern in the amount range of $15,001 - $50,000, with Joint listed as the owner. It does not establish Kevin Hern's total holdings in MDT, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Medtronic plc. Ordinary Shares (MDT) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Kevin Hern's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Kevin Hern disclosed 1 other MDT transaction (1 sale) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded MDT?

Quantellect's current database lists these recent MDT disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
Richard Dean Dr McCormick SelfR HouseSell$1,001 - $15,000August 14, 2026Filing unavailable
Rohit Khanna SpouseD HouseBuy$1,001 - $15,000June 9, 2026Filing unavailable
Rohit Khanna SpouseD HouseBuy$1,001 - $15,000June 9, 2026Filing unavailable
Gilbert Cisneros SelfD HouseSell$1,001 - $15,000June 8, 2026Filing unavailable
Rohit Khanna Dependent childD HouseSell$1,001 - $15,000April 7, 2026Filing unavailable

How has Kevin Hern's disclosed trading performed?

Kevin Hern holds a Quantellect Q Score of 10 (weak), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.

Q Score rank #70 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.

All Kevin Hern MDT trades

TradedTypeSizeReturnEst. profit
August 24, 2026Sell$15,001 - $50,000+1.37%
March 20, 2026Sell$15,001 - $50,000+10.19%
January 31, 2023Sell$1,001 - $15,000+25.10%
December 20, 2021Sell$100,001 - $250,000+9.13%
September 23, 2021Buy$100,001 - $250,000-16.85%-$28K
July 1, 2021Buy$15,001 - $50,000-13.46%-$4K
July 27, 2020Buy$1,001 - $15,000+15.56%+$1K
November 7, 2019Buy$1,001 - $15,000+6.19%+$572

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Kevin Hern buy or sell MDT?

According to the disclosure, Kevin Hern sold MDT on August 24, 2026.

What amount was reported for the MDT transaction?

The disclosure reports $15,001 - $50,000 for the sale. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated August 24, 2026, and it was disclosed on September 1, 2026.

Where can I see Kevin Hern's other congressional trades?

Quantellect lists Kevin Hern's complete disclosed trade history on the member profile. Kevin Hern's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Q Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.